Arcadia Biosciences, Inc.
corporate_fare Company Profile
Arcadia Biosciences, Inc. (NASDAQ:RKDA) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 22 items for RKDA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-04, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 17 rated 8 or above. Recent SEC coverage for RKDA spans 8-K, 10-Q, PRE 14A, 424B3.
Recent high-impact activity:
- Second Nasdaq Delisting Notice Hits Arcadia Biosciences Over Equity Shortfall
- Arcadia Biosciences Q2 Net Loss Widens to $6.27M on Financing Valuation Loss
- Arcadia Biosciences Q2 Loss Widens to $6.27M; Going Concern and Nasdaq Delisting Risks Mount
- Arcadia Biosciences Q2 Loss Widens to $6.3M, but Zola Sales Inflect with July Revenue Topping $740K
- Arcadia Biosciences Faces Nasdaq Delisting Over Sub-$1 Bid Price
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for RKDA, detected from its recent SEC filings · based on capital-structure filings through 2026-07-08.
Resale of 11.9 Million Shares Activated · Massive Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →